학술논문

DMF Attenuates Ciprofloxacin-Induced Nephropathy in Rats via Nrf2 Pathway.
Document Type
Article
Source
Journal of Pharmaceutical Negative Results. 2022, Vol. 13 Issue 2, p87-91. 5p.
Subject
*RATS
*NUCLEAR factor E2 related factor
*BLOOD urea nitrogen
*DIMETHYL fumarate
*ANTIOXIDANT analysis
*KIDNEY diseases
Language
ISSN
0976-9234
Abstract
Background: The pathophysiology of ciprofloxacin-induced nephropathy (CIN) is complicated by oxidative stress. The goal of this study was to see if Dimethyl Fumarate (DMF) has any antioxidant properties in a rat model of CIN. Methods: Rats were randomly assigned to six groups (n=8): control, ciprofloxacin (ciprofloxacin-induced CIN), two DMF groups (rats treated with DMF 50mg and 100mg), and two ciprofloxacin Plus DMF groups (n=8/group) (CIN rats treated with DMF at 50 mg and 100 mg). Renal function testing, Nrf2 analysis, and anti-oxidant enzymes analysis was all done. Results: Following ciprofloxacin therapy, serum blood urea nitrogen (BUN), creatinine, and anti-oxidant enzymes all rose. In the ciprofloxacin + DMF groups, serum BUN and creatinine were lower, and anti-oxidant enzymes were higher than in the ciprofloxacin group, in CIN rats, DMF upregulated Nrf2 expression. Conclusions: In vivo, DMF reduces experimental CIN. It's thought that this impact activates the Nrf2 antioxidant defenses pathway. [ABSTRACT FROM AUTHOR]